These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34424600)

  • 1. LncRNA AC020978 facilitates non-small cell lung cancer progression by interacting with malate dehydrogenase 2 and activating the AKT pathway.
    Xu F; Hua Q; Zhang A; Di Z; Wang Y; Zhao L; Yang H; Liu J; Huang G
    Cancer Sci; 2021 Nov; 112(11):4501-4514. PubMed ID: 34424600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced lncRNA-AC020978 promotes proliferation and glycolytic metabolism of non-small cell lung cancer by regulating PKM2/HIF-1α axis.
    Hua Q; Mi B; Xu F; Wen J; Zhao L; Liu J; Huang G
    Theranostics; 2020; 10(11):4762-4778. PubMed ID: 32308748
    [No Abstract]   [Full Text] [Related]  

  • 3. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
    Tang Y; Xiao G; Chen Y; Deng Y
    Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA HOXB-AS3 exacerbates proliferation, migration, and invasion of lung cancer via activating the PI3K-AKT pathway.
    Jiang W; Kai J; Li D; Wei Z; Wang Y; Wang W
    J Cell Physiol; 2020 Oct; 235(10):7194-7203. PubMed ID: 32039488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA FAL1 Promotes Cell Proliferation, Invasion and Epithelial-Mesenchymal Transition Through the PTEN/AKT Signaling Axis in Non-Small Cell Lung Cancer.
    Pan C; Yao G; Liu B; Ma T; Xia Y; Wei K; Wang J; Xu J; Chen L; Chen Y
    Cell Physiol Biochem; 2017; 43(1):339-352. PubMed ID: 28854421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA PCAT1 Interacts with DKC1 to Regulate Proliferation, Invasion and Apoptosis in NSCLC Cells via the VEGF/AKT/Bcl2/Caspase9 Pathway.
    Liu SY; Zhao ZY; Qiao Z; Li SM; Zhang WN
    Cell Transplant; 2021; 30():963689720986071. PubMed ID: 33461333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linc8087 predicts favorable prognosis and inhibits cell migration and invasion in NSCLC.
    Qi Q; Chen C; Liu C; Zhang B; Ma Y; Zhang H; Huang W; Wang C
    Pathol Res Pract; 2021 Sep; 225():153569. PubMed ID: 34391179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C; Li X; Hao Y; Wang F; Cheng Z; Geng H; Geng D
    Aging (Albany NY); 2020 May; 12(9):8680-8701. PubMed ID: 32396871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
    Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
    Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA DDX11-AS1 promotes non-small cell lung cancer development via regulating PI3K/AKT signalling.
    Feng X; Yang S; Zhou S; Deng S; Xie Y
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1622-1631. PubMed ID: 32298476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway.
    Yu T; Zhao Y; Hu Z; Li J; Chu D; Zhang J; Li Z; Chen B; Zhang X; Pan H; Li S; Lin H; Liu L; Yan M; He X; Yao M
    Cancer Res; 2017 Nov; 77(21):5782-5794. PubMed ID: 28923857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long non-coding RNA MIAT/miR-139-5p/MMP2 axis regulates cell migration and invasion in non-small-cell lung cancer.
    Zeng F; Yu N; Han Y; Ainiwaer J
    J Biosci; 2020; 45():. PubMed ID: 32345777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC01093 promotes proliferation and invasion of non-small cell lung cancer cells via targeting akt signaling pathway.
    Wang ZX; Xu ZN; Sun HB; Wang Y; Han ZF; Yu Y; Han XL; Yin YY; Xu L
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):222-229. PubMed ID: 31957835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge.
    Lingling J; Xiangao J; Guiqing H; Jichan S; Feifei S; Haiyan Z
    Biomed Pharmacother; 2019 Apr; 112():108648. PubMed ID: 30780105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
    Sun M; Liu XH; Wang KM; Nie FQ; Kong R; Yang JS; Xia R; Xu TP; Jin FY; Liu ZJ; Chen JF; Zhang EB; De W; Wang ZX
    Mol Cancer; 2014 Mar; 13():68. PubMed ID: 24655544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small-cell lung cancer.
    Zhang E; Li W; Yin D; De W; Zhu L; Sun S; Han L
    Tumour Biol; 2016 Mar; 37(3):4007-15. PubMed ID: 26482621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell adhesion molecule 4 suppresses cell growth and metastasis by inhibiting the Akt signaling pathway in non-small cell lung cancer.
    Luo F; Zhao Y; Liu J
    Int J Biochem Cell Biol; 2020 Jun; 123():105750. PubMed ID: 32325280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.